Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Resonance Health Ltd ( (AU:RHT) ) just unveiled an announcement.
Resonance Health Ltd has announced the cessation of Dr. Martin Peter Blake as a director, effective November 13, 2025. Dr. Blake held significant interests in the company, with 3,798,590 ordinary fully paid shares directly and an additional 2,666,087 shares through a superannuation fund. This change in directorship may impact the company’s governance and strategic direction, given Dr. Blake’s substantial shareholding and involvement.
More about Resonance Health Ltd
Resonance Health Ltd operates in the medical imaging industry, providing non-invasive diagnostic imaging solutions primarily focused on liver health. The company is known for its innovative MRI-based technology that aids in the detection and management of liver disorders, serving a global market with a focus on improving patient outcomes.
Average Trading Volume: 377,806
Technical Sentiment Signal: Hold
Current Market Cap: A$22.3M
Learn more about RHT stock on TipRanks’ Stock Analysis page.